1: Weinberg R, Kaurin DG, Choy H, Curran WJ Jr, MacRae R, Kim JS, Kim J, Tucker SL, Bonomi PD, Belani C, Starkschall G. Dosimetric uncertainties of three-dimensional dose reconstruction from two-dimensional data in a multi-institutional study. J Appl Clin Med Phys. 2004 Autumn;5(4):15-28. Epub 2004 Oct 1. PMID: 15738918 [PubMed - in process]

2: Werner-Wasik M, Langer C, Movsas B. Randomized phase II study of amifostine mucosal protection by either subcutaneous injection or rapid IV bolus for patients with inoperable stage II-IIIA/B or stage IV non-small cell lung cancer with oligometastases receiving concurrent radiochemotherapy with carboplatin and paclitaxel followed by optional consolidative chemotherapy: a follow-up study after RTOG 98-01. Semin Oncol. 2004 Dec;31(6 Suppl 18):47-51. Review. PMID: 15726523

3: Lustig RA, Scott CB, Curran WJ. Does stereotactic eligibility for the treatment of glioblastoma cause selection bias in randomized studies? Am J Clin Oncol. 2004 Oct;27(5):516-21. PMID: 15596923

4: Wernicke AG, Valicenti R, Dieva K, Houser C, Pequignot E. Radiation dose delivered to the proximal penis as a predictor of the risk of erectile dysfunction after three-dimensional conformal radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2004 Dec 1;60(5):1357-63. PMID: 15590165

5: Bucci MK, Rosenthal DI, Hershock D, Metz J, Devine P, Kligerman MM, Machtay M. Final report of a pilot trial of accelerated radiotherapy plus concurrent 96-hour infusional paclitaxel for locally advanced head and neck cancer. Am J Clin Oncol. 2004 Dec;27(6):595-602. PMID: 15577438

6: Febles C, Valicenti RK. Combining external beam radiotherapy with prostate brachytherapy: issues and rationale. Urology. 2004 Nov;64(5):855-61. Review. PMID: 15533463

7: Gupta AK, Soto DE, Feldman MD, Goldsmith JD, Mick R, Hahn SM, Machtay M, Muschel RJ, McKenna WG. Signaling pathways in NSCLC as a predictor of outcome and response to therapy. Lung. 2004;182(3):151-62. PMID: 15526754

8: Charara M, Edmonston TB, Burkholder S, Walters R, Anne P, Mitchell E, Fry R, Boman B, Rose D, Fishel R, Curran W, Palazzo J. Microsatellite status and cell cycle associated markers in rectal cancer patients undergoing a combined regimen of 5-FU and CPT-11 chemotherapy and radiotherapy. Anticancer Res. 2004 Sep-Oct;24(5B):3161-7. PMID: 15510606

9: Wachsberger P, Burd R, Dicker AP. Improving tumor response to radiotherapy by targeting angiogenesis signaling pathways. Hematol Oncol Clin North Am. 2004 Oct;18(5):1039-57, viii. Review. PMID: 15474334

10: Souhami L, Seiferheld W, Brachman D, Podgorsak EB, Werner-Wasik M, Lustig R, Schultz CJ, Sause W, Okunieff P, Buckner J, Zamorano L, Mehta MP, Curran WJ Jr. Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol. Int J Radiat Oncol Biol Phys. 2004 Nov 1;60(3):853-60. PMID: 15465203

11: Xiao Y, Michalski D, Censor Y, Galvin JM. Inherent smoothness of intensity patterns for intensity modulated radiation therapy generated by simultaneous projection algorithms. Phys Med Biol. 2004 Jul 21;49(14):3227-45. PMID: 15357194

12: Boccia R, Anne PR, Bourhis J, Brizel D, Daly C, Holloway N 3rd, Hymes S, Koukourakis M, Kozloff M, Turner M, Wasserman T. Assessment and management of cutaneous reactions with amifostine administration: findings of the ethyol (amifostine) cutaneous treatment advisory panel (ECTAP). Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):302-9. Review. PMID: 15337569

13: Veznedaroglu E, Andrews DW, Benitez RP, Downes MB, Werner-Wasik M, Rosenstock J, Curran WJ Jr, Rosenwasser RH. Fractionated stereotactic radiotherapy for the treatment of large arteriovenous malformations with or without previous partial embolization. Neurosurgery. 2004 Sep;55(3):519-30; discussion 530-1. PMID: 15335419

15: Xiao Y, Werner-Wasik M, Michalski D, Houser C, Bednarz G, Curran W, Galvin J. Comparison of three IMRT inverse planning techniques that allow for partial esophagus sparing in patients receiving thoracic radiation therapy for lung cancer. Med Dosim. 2004 Fall;29(3):210-6. PMID: 15324918

15: Bruner DW, Movsas B, Konski A, Roach M, Bondy M, Scarintino C, Scott C, Curran W. Outcomes research in cancer clinical trial cooperative groups: the RTOG model. Qual Life Res. 2004 Aug;13(6):1025-41. PMID: 15287270

16: McElveen TL, Waterman FM, Kim H, Dicker AP. Factors predicting for urinary incontinence after prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2004 Aug 1;59(5):1395-404. PMID: 15275725

17: Bednarz G, Michalski D, Anne PR, Valicenti RK. Inverse treatment planning using volume-based objective functions. Phys Med Biol. 2004 Jun 21;49(12):2503-14. PMID: 15272670

18: Chen Y, Hou Q, Galvin JM. A graph-searching method for MLC leaf sequencing under constraints. Med Phys. 2004 Jun;31(6):1504-11. PMID: 15259654

19: Lee HM, Solan MJ, Lupinacci P, Gomella LG, Valicenti RK. Long-term outcome of patients with prostate cancer and pathologic seminal vesicle invasion (pT3b): effect of adjuvant radiotherapy. Urology. 2004 Jul;64(1):84-9. PMID: 15245941

20: Chang SM, Seiferheld W, Curran W, Share R, Atkins J, Choucair A, Kresl J, Thoron L, Cairncross G, Gilbert M, Bahary JP, Dolinskas C, Louis DN, Bushunow P, Buckner J, Barger G, Mehta M. Phase I study pilot arms of radiotherapy and carmustine with temozolomide for anaplastic astrocytoma (Radiation Therapy Oncology Group 9813): implications for studies testing initial treatment of brain tumors. Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):1122-6. PMID: 15234047

21: Gordon AR, Loevner LA, Shukla-Dave A, Redfern RO, Sonners AI, Kilger AM, Elliott MA, Machtay M, Weber RS, Glickson JD, Rosenthal DI. Intraobserver variability in the MR determination of tumor volume in squamous cell carcinoma of the pharynx. AJNR Am J Neuroradiol. 2004 Jun-Jul;25(6):1092-8. PMID: 15205156

22: Kelloff GJ, Coffey DS, Chabner BA, Dicker AP, Guyton KZ, Nisen PD, Soule HR, D'Amico AV. Prostate-specific antigen doubling time as a surrogate marker for evaluation of oncologic drugs to treat prostate cancer. Clin Cancer Res. 2004 Jun 1;10(11):3927-33. Review. No abstract available. PMID: 15173102

23: Woude GF, Kelloff GJ, Ruddon RW, Koo HM, Sigman CC, Barrett JC, Day RW, Dicker AP, Kerbel RS, Parkinson DR, Slichenmyer WJ. Reanalysis of cancer drugs: old drugs, new tricks. Clin Cancer Res. 2004 Jun 1;10(11):3897-907. Review. No abstract available. PMID: 15173099

24: Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, Werner-Wasik M, Demas W, Ryu J, Bahary JP, Souhami L, Rotman M, Mehta MP, Curran WJ Jr. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet. 2004 May 22;363(9422):1665-72. PMID: 15158627

25: Brat DJ, Seiferheld WF, Perry A, Hammond EH, Murray KJ, Schulsinger AR, Mehta MP, Curran WJ; Radiation Therapy Oncology Group. Analysis of 1p, 19q, 9p, and 10q as prognostic markers for high-grade astrocytomas using fluorescence in situ hybridization on tissue microarrays from Radiation Therapy Oncology Group trials. Neuro-oncol. 2004 Apr;6(2):96-103. PMID: 15134623

26: Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, Machtay M, Ensley JF, Chao KS, Schultz CJ, Lee N, Fu KK; Radiation Therapy Oncology Group 9501/Intergroup. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004 May 6;350(19):1937-44. PMID: 15128893

27: Ryden M, Arvidsson E, Blomqvist L, Perbeck L, Dicker A, Arner P. Targets for TNF-alpha-induced lipolysis in human adipocytes. Biochem Biophys Res Commun. 2004 May 21;318(1):168-75. PMID: 15110769

28: Brown PD, Buckner JC, O'Fallon JR, Iturria NL, O'Neill BP, Brown CA, Scheithauer BW, Dinapoli RP, Arusell RM, Curran WJ, Abrams R, Shaw EG; North Central Cancer Treatment Group; Mayo Clinic. Importance of baseline mini-mental state examination as a prognostic factor for patients with low-grade glioma. Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):117-25. PMID: 15093907

29: Machtay M, Rosenthal DI, Chalian AA, Lustig R, Hershock D, Miller L, Weinstein GS, Weber RS. Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):72-7. PMID: 15093901

30: Lanza-Jacoby S, Dicker AP, Miller S, Rosato FE, Flynn JT, Lavorgna SN, Burd R. Cyclooxygenase (COX)-2-dependent effects of the inhibitor SC236 when combined with ionizing radiation in mammary tumor cells derived from HER-2/neu mice. Mol Cancer Ther. 2004 Apr;3(4):417-24. PMID: 15078985

31: Galvin JM, Ezzell G, Eisbrauch A, Yu C, Butler B, Xiao Y, Rosen I, Rosenman J, Sharpe M, Xing L, Xia P, Lomax T, Low DA, Palta J; American Society for Therapeutic Radiology and Oncology; American Association of Physicists in Medicine. Implementing IMRT in clinical practice: a joint document of the American Society for Therapeutic Radiology and Oncology and the American Association of Physicists in Medicine. Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1616-34. No abstract available. PMID: 15050343

32: Forsberg F, Ro RJ, Potoczek M, Liu JB, Merritt CR, James KM, Dicker AP, Nazarian LN. Assessment of angiogenesis: implications for ultrasound imaging. Ultrasonics. 2004 Apr;42(1-9):325-30. PMID: 15047306

33: Werner-Wasik M, Yu X, Marks LB, Schultheiss TE. Normal-tissue toxicities of thoracic radiation therapy: esophagus, lung, and spinal cord as organs at risk. Hematol Oncol Clin North Am. 2004 Feb;18(1):131-60, x-xi. Review. PMID: 15005286

34: Jeremic B, Machtay M. Concurrent radiochemotherapy in the treatment of locally advanced non-small cell lung cancer. Hematol Oncol Clin North Am. 2004 Feb;18(1):91-100. Review. PMID: 15005283

35: Michalski D, Xiao Y, Censor Y, Galvin JM. The dose-volume constraint satisfaction problem for inverse treatment planning with field segments. Phys Med Biol. 2004 Feb 21;49(4):601-16. PMID: 15005168

36: Brown PD, Buckner JC, O'Fallon JR, Iturria NL, Brown CA, O'Neill BP, Scheithauer BW, Dinapoli RP, Arusell RM, Abrams RA, Curran WJ, Shaw EG; North Central Cancer Treatment Group; Mayo Clinic. Adult patients with supratentorial pilocytic astrocytomas: a prospective multicenter clinical trial. Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1153-60. PMID: 15001258

37: Prados MD, Seiferheld W, Sandler HM, Buckner JC, Phillips T, Schultz C, Urtasun R, Davis R, Gutin P, Cascino TL, Greenberg HS, Curran WJ Jr. Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404. Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1147-52. PMID: 15001257

38: Valicenti RK, Chervoneva I, Gomella LG. Importance of margin extent as a predictor of outcome after adjuvant radiotherapy for Gleason score 7 pT3N0 prostate cancer. Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1093-7. PMID: 15001249

39: Sidhu K, Cooper P, Ramani R, Schwartz M, Franssen E, Davey P. Delineation of brain metastases on CT images for planning radiosurgery: concerns regarding accuracy. Br J Radiol. 2004 Jan;77(913):39-42. PMID: 14988136

40: Chakravarti A, Dicker A, Mehta M. The contribution of epidermal growth factor receptor (EGFR) signaling pathway to radioresistance in human gliomas: a review of preclinical and correlative clinical data. Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):927-31. Review. PMID: 14967452

41: Dicker AP, Rodeck U. Targeting the EGFR in neoplasia--more questions than answers. Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):899-902. No abstract available. PMID: 14967449

42: Michalski JM, Winter K, Purdy JA, Perez CA, Ryu JK, Parliament MB, Valicenti RK, Roach M 3rd, Sandler HM, Markoe AM, Cox JD. Toxicity after three-dimensional radiotherapy for prostate cancer with RTOG 9406 dose level IV. Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):735-42. PMID: 14967428

43: Machtay M, Lee JH, Stevenson JP, Shrager JB, Algazy KM, Treat J, Kaiser LR. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response. J Thorac Cardiovasc Surg. 2004 Jan;127(1):108-13. PMID: 14752420

44: Meyers CA, Smith JA, Bezjak A, Mehta MP, Liebmann J, Illidge T, Kunkler I, Caudrelier JM, Eisenberg PD, Meerwaldt J, Siemers R, Carrie C, Gaspar LE, Curran W, Phan SC, Miller RA, Renschler MF. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol. 2004 Jan 1;22(1):157-65. PMID: 14701778

45: Machtay M. Phase I's, photons, and philosophies: new tactics for exploratory clinical trials of concurrent chemoradiation. J Clin Oncol. 2004 Jan 15;22(2):214-6. Epub 2003 Dec 9. No abstract available. PMID: 14665615

46: Hargis MT, Storck CW, Wickstrom E, Yakubov LA, Leeper DB, Coss RA. Hsp27 anti-sense oligonucleotides sensitize the microtubular cytoskeleton of Chinese hamster ovary cells grown at low pH to 42 degrees C-induced reorganization. Int J Hyperthermia. 2004 Aug;20(5):491-502. Erratum in: Int J Hyperthermia. 2005Feb;21(1):89. PMID: 15277022

47: Sekins KM, Leeper DB, Hoffman JK, Keilman GW, Ziskin MC, Wolfson MR, Shaffer TH. Feasibility of lung cancer hyperthermia using breathable perfluorochemical (PFC) liquids. Part II: Ultrasound hyperthermia. Int J Hyperthermia. 2004 May;20(3):278-99. PMID: 15204526

48: Sekins KM, Leeper DB, Hoffman JK, Wolfson MR, Shaffer TH. Feasibility of lung cancer hyperthermia using breathable perfluorochemical (PFC) liquids. Part I: Convective hyperthermia. Int J Hyperthermia. 2004 May;20(3):252-77. PMID: 15204525

49: Canter RJ, Zhou R, Kesmodel SB, Zhang Y, Heitjan DF, Glickson JD, Leeper DB, Fraker DL. Metaiodobenzylguanidine and hyperglycemia augment tumor response to isolated limb perfusion in a rodent model of human melanoma. Ann Surg Oncol. 2004 Mar;11(3):265-73. PMID: 14993021

50: Coss RA, Storck CW, Wachsberger PR, Reilly J, Leeper DB, Berd D, Wahl ML. Acute extracellular acidification reduces intracellular pH, 42 degrees C-induction of heat shock proteins and clonal survival of human melanoma cells grown at pH 6.7. Int J Hyperthermia. 2004 Feb;20(1):93-106. PMID: 14612316

51: Wang H, Wang H, Powell SN, Iliakis G, Wang Y. ATR affecting cell radiosensitivity is dependent on homologous recombination repair but independent of nonhomologous end joining. Cancer Res. 2004 Oct 1;64(19):7139-43. PMID: 15466211

52: Perrault R, Wang H, Wang M, Rosidi B, Iliakis G. Backup pathways of NHEJ are suppressed by DNA-PK. J Cell Biochem. 2004 Jul 1;92(4):781-94. PMID: 15211575

53: Wang X, Guan J, Hu B, Weiss RS, Iliakis G, Wang Y. Involvement of Hus1 in the chain elongation step of DNA replication after exposure to camptothecin or ionizing radiation. Nucleic Acids Res. 2004 Feb 3;32(2):767-75. Print 2004. PMID: 14762204

54: Wang H, Boecker W, Wang H, Wang X, Guan J, Thompson LH, Nickoloff JA,Iliakis G. Caffeine inhibits homology-directed repair of I-SceI-induced DNA double-strand breaks. Oncogene. 2004 Jan 22;23(3):824-34. PMID: 14737117